GL1X · GenesisL1 explorer

Research workbench

X-ray studies of aspartic proteinase-statine inhibitor complexes.

Analyse X-ray studies of aspartic proteinase-statine inhibitor complexes. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ER9
Type
protein
Length
336 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Endothiapepsin; L363,564
EC
3.4.23.6
UniProt
P11838
Ligands
BOC

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
EEndothiapepsin (EC 3.4.23.6)protein33010% helix, 47% strandP11838
IL363,564protein60% helix, 17% strand—

Ligands and binding sites

  • BOC · Tert-butyl hydrogen carbonate · ligand · chains E, I

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

1 interface between chains.

  • E–I · 708 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent, 1 disulfide, 1 modified (covalent ligand, disulfide, nonstandard).

Compared structures

  • 2ER9 · X-ray studies of aspartic proteinase-statine inhibitor complexes. · the same entry in another collection · chain E against E, TM-score 1.00
  • P11838 · AlphaFold monomer V2.0 prediction for endothiapepsin (P11838) · a predicted model of the same protein · chain E against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.